News

New NMDAR modulator shows promise for pain relief and stress reduction in early animal studies April 29, 2025 N -Methyl-D-aspartate (NMDA)-subtype glutamate receptors are an attractive target for ...
Recovery from an autoimmune inflammation of the brain may take three years or more, according to a study published in the November 20, 2024, online issue of Neurology. Anti-N-methyl-D-aspartate ...
They demonstrated that administering an NMDAR antagonist during the initial phase of SWE prevented this synaptic strengthening. In addition, application of an NMDAR antagonist blocked the LTP that ...